These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38330918)

  • 41. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
    Hamaguchi M; Kojima T; Takeda N; Nakagawa T; Taniguchi H; Fujii K; Omatsu T; Nakajima T; Sarui H; Shimazaki M; Kato T; Okuda J; Ida K
    Ann Intern Med; 2005 Nov; 143(10):722-8. PubMed ID: 16287793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B.
    Han E; Lee YH; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH; Kim SU
    Aliment Pharmacol Ther; 2018 Aug; 48(3):300-312. PubMed ID: 29920701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.
    Manco M
    J Am Coll Nutr; 2011 Oct; 30(5):295-303. PubMed ID: 22081615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014.
    Fermin CR; Lee AM; Filipp SL; Gurka MJ; DeBoer MD
    Metab Syndr Relat Disord; 2017 Aug; 15(6):276-282. PubMed ID: 28520503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis.
    Kim D; Kim W; Joo SK; Han J; Kim JH; Harrison SA; Younossi ZM; Ahmed A
    J Gastroenterol; 2020 Mar; 55(3):330-341. PubMed ID: 31535207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome.
    Kositamongkol C; Charernboon T; Chaisathaphol T; Washirasaksiri C; Auesomwang C; Sitasuwan T; Charatcharoenwitthaya P; Phisalprapa P
    Medicine (Baltimore); 2021 Nov; 100(44):e27640. PubMed ID: 34871234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.
    Arvind A; Henson JB; Osganian SA; Nath C; Steinhagen LM; Memel ZN; Donovan A; Balogun O; Chung RT; Simon TG; Corey KE
    Hepatol Commun; 2022 Feb; 6(2):309-319. PubMed ID: 34558862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of Adolescent Obesity with Nonalcoholic Fatty Liver Disease and Related Risk Factors in Xi 'an, China.
    Rong Y; Chun-Yan N; Hong-Xin Z; Lu Y; Wen W; Yu T
    Ann Hepatol; 2018; 17(1):85-91. PubMed ID: 29311392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence and Clinical Significance of Autoantibodies in Children with Overweight and Obesity with Nonalcoholic Fatty Liver Disease.
    Khayat A; Vitola B
    J Pediatr; 2021 Dec; 239():155-160. PubMed ID: 34454951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of Nonalcoholic Fatty Liver Disease in Normal-weight and Overweight Preadolescent Children in Haryana, India.
    Das MK; Bhatia V; Sibal A; Gupta A; Gopalan S; Sardana R; Sahni R; Roy A; Arora NK
    Indian Pediatr; 2017 Dec; 54(12):1012-1016. PubMed ID: 29317557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children.
    Prokopowicz Z; Malecka-Tendera E; Matusik P
    Can J Gastroenterol Hepatol; 2018; 2018():9465784. PubMed ID: 29854716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fatty liver in adolescents on the U.S.-Mexico border.
    Sharp DB; Santos LA; Cruz ML
    J Am Acad Nurse Pract; 2009 Apr; 21(4):225-30. PubMed ID: 19366381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents.
    Belei O; Olariu L; Dobrescu A; Marcovici T; Marginean O
    J Pediatr Endocrinol Metab; 2017 Oct; 30(11):1161-1168. PubMed ID: 28988228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nonalcoholic fatty liver disease prevalence in urban school-aged children and adolescents from the Yangtze River delta region: a cross-sectional study.
    Zhang X; Wan Y; Zhang S; Lu L; Chen Z; Liu H; Jiang X; Luo K; Cai W
    Asia Pac J Clin Nutr; 2015; 24(2):281-8. PubMed ID: 26078245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.
    Kouvari M; Polyzos SA; Chrysohoou C; Skoumas J; Pitsavos CS; Panagiotakos DB; Mantzoros CS
    Clin Nutr; 2022 Jun; 41(6):1281-1289. PubMed ID: 35504171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents.
    Liang S; Cheng X; Hu Y; Song R; Li G
    Acta Paediatr; 2017 Feb; 106(2):298-303. PubMed ID: 27889912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease.
    Bhat G; Baba CS; Pandey A; Kumari N; Choudhuri G
    Trop Gastroenterol; 2013; 34(1):18-24. PubMed ID: 23923370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Establishing international optimal cut-offs of waist-to-height ratio for predicting cardiometabolic risk in children and adolescents aged 6-18 years.
    Zong X; Kelishadi R; Hong YM; Schwandt P; Matsha TE; Mill JG; Whincup PH; Pacifico L; López-Bermejo A; Caserta CA; Medeiros CCM; Kollias A; Qorbani M; Jazi FS; Haas GM; de Oliveira Alvim R; Zaniqueli D; Chiesa C; Bassols J; Romeo EL; de Carvalho DF; da Silva Simões MO; Stergiou GS; Grammatikos E; Zhao M; Magnussen CG; Xi B
    BMC Med; 2023 Nov; 21(1):442. PubMed ID: 37968681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.